StrideBio stridebio.com


Public list: Pharma Startups (6570) Rare Diseases (230)

StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. The company is building a proprietary therapeutic pipeline focused on rare diseases.

StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. The company is building a proprietary therapeutic pipeline focused on rare diseases.

Company (Alive / Active)

Phone: 302-290-5544

Fax:

5 Laboratory Dr
Suite 1200
Research Triangle Park, 27709
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
StrideBio $98.2M Mar 16, 2021

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related StrideBio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Patents

Title Application Date Patent Date Status
(Patent / Application)